Welcome to our dedicated page for Givbux SEC filings (Ticker: GBUX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how a cashback-to-charity Super App makes money isn’t easy—especially when GivBux’s disclosures pack payment data, merchant incentives, and donation accruals into hundreds of pages. If you’ve ever asked, “Where can I decode GivBux SEC filings explained simply?” this page is the answer.
Stock Titan distills every document the moment it hits EDGAR. Our AI-powered summaries flag what matters—whether a GivBux 8-K material events explained note announces a new retail partner or a GivBux quarterly earnings report 10-Q filing reveals gross merchandise volume trends. Stop scrolling line by line; key metrics like charitable payout ratios surface instantly.
Wondering if insiders still believe in the model? Monitor GivBux Form 4 insider transactions real-time. Each filing links to concise context so you understand executive intent behind every buy or sell. Need the full story? Our platform keeps the complete archive, from the GivBux annual report 10-K simplified to each proxy statement on executive pay.
- GivBux insider trading Form 4 transactions – see patterns before they hit the news
- GivBux proxy statement executive compensation – review incentive alignment
- understanding GivBux SEC documents with AI – plain-English explanations
- GivBux earnings report filing analysis – segment revenue, cash burn, outlook
No matter the filing type, real-time alerts and expert commentary turn dense disclosures into actionable insight. Access everything in one place, save hours of manual review, and make informed decisions faster.
GivBux Inc. (GBUX) reported Q3 2025 results showing a sharp swing to a net gain of $3.34 million, compared with a net loss of $0.22 million a year earlier. This was driven almost entirely by a $4.24 million non‑cash gain from the change in fair value of derivative liabilities, while core operations remained loss‑making.
Revenue for Q3 2025 fell to $89,988 from $257,920 as the company reduced beta‑test related promotions; nine‑month revenue declined to $211,814 from $330,319. For the first nine months of 2025, GivBux recorded a net loss of $3.29 million, similar to the prior‑year loss.
The balance sheet is very weak: at September 30, 2025, GivBux had $208,696 in total assets, $5.60 million in liabilities, a working capital deficit of $5.41 million, cash of only $82,383, and an accumulated deficit of $33.39 million. Management discloses substantial doubt about the company’s ability to continue as a going concern, citing dependence on raising additional equity or debt financing.
GivBux Inc. (GBUX) filed a Form 12b-25 (NT 10-Q), notifying a late filing for its Quarterly Report for the period ended September 30, 2025. Management states the company was “unable to compile the information necessary for the preparation of the Company's financial statements” in time, and that filing within the deadline would have required unreasonable effort or expense.
Contact listed: Michael Arnkvarn, Director, at (613) 222-5097.
GIVBUX, Inc. amends its S-1 registration showing a complex capital and liquidity picture. The company reports
The company disclosed corporate restructuring around a 1-for-20 reverse split, FINRA-required pre-split share issuances totaling 78,125,000 shares and an additional contractual issuance of 74,218,050 post-split shares related to a share exchange with GivBux Global Partners, Inc., resulting in corporate ownership changes and potential limitations on net operating loss carryforwards under Section 382. Recent financings provided modest cash proceeds (examples:
GivBux, Inc. amended its annual report to disclose capital structure, debt instruments, related-party transactions and governance weaknesses. The company has common stock outstanding in the high tens of millions (examples: 94,572,767 and 88,572,767 reported), and authorized series of preferred and Series C shares of $0.001 par value. Multiple convertible notes carry 10% OID, stated annual rates of 10%–20%, and conversion features including fixed $0.50 prices and discounts of 25%–55% to market prices, creating potential dilution. The filing notes note defaults and unamortized debt discounts (examples: $126,839 unamortized discount and accrued interest balances shown). The company described related-party and share-exchange transactions involving GivBux Global and a planned metaverse subsidiary with contingent preferred-stock issuances. It also discloses a foreclosure balance of $64,000 payable by January 15, 2025, and identified material weaknesses in controls, including lack of an audit committee and separation of duties.
FAQ
What is the current stock price of Givbux (GBUX)?
What is the market cap of Givbux (GBUX)?
